Evidence map›Paper›PMID 19731547›Full record

ReviewAdvances in experimental medicine and biology2009

Dopamine systems in the forebrain.

John W Cave, Harriet Baker

Open access · greenAbstract readReview
In one paragraph

Review in Advances in experimental medicine and biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
18.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. A systematic review on olfaction in child and adolescent psychiatric disorders.Journal of neural transmission (Vienna, Austria : 1996) · 2013
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Cocaine perturbs mitovesicle biology in the brain.Journal of extracellular vesicles · 2023
    Article
  8. Article
  9. Olfactory Bulb DToxins · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

John W CaveDepartment of Neurology and Neuroscience, Weill Cornell Medical College, Burke Medical Research Institute, White Plains, NY 10606, USA.
Harriet Baker
Burke Medical Research Institute · US

Funding

Plasticity in the Aging Olfactory SystemR01DC008955 · NIDCD · WINIFRED MASTERSON BURKE MED RES INST · PI BAKER, HARRIET D., CAVE, JOHN W · 2008 to 2015
$4.6M
NIDCD NIH HHS R01 DC008955NIDCD NIH HHS R01-DC008955
6 · The paper itself

Abstract

The brain contains a number of distinct regions that share expression ofdopamine (DA) and its requisite biosynthetic machinery, but otherwise encompass a diverse array of features and functions. Across the vertebrate family, the olfactory bulb (OB) contains the major DA system in the forebrain. OB DA cells are primarily periglomerular interneurons that define the glomerular structures in which they receive innervation from olfactory receptor neurons as well as mitral and tufted cells, the primary OB output neurons. The OB DA cells are necessary for both discrimination and the dynamic range over which odorant sensory information can be detected. In the embryo, OB DA neurons are derived from the ventricular area of the evaginating telencephalon, the dorsal lateral ganglionic eminence and the septum. However, most OB DA interneurons are generated postnatally and continue to be produced throughout adult life from neural stem cells in the subventricular zone of the lateral ventricle and rostral migratory stream. Adult born OB DA neurons are capable of integrating into existing circuits and do not appear to degenerate in Parkinson's disease. Several genes have been identified that regulate the differentiation of OB DA interneurons from neural stem cells. These include transcription factors that modify the expression of tyrosine hydroxylase, the first enzyme in the DA biosynthetic pathway and a reliable marker of the DA phenotype. Elucidation of the molecular genetic pathways of OB DA differentiation may advance the development of strategies to treat neurological disease.

Indexed as

AnimalsDopamineHumansInterneuronsNeurogenesisOlfactory BulbOlfactory PathwaysProsencephalonSmellSynaptic TransmissionTyrosine 3-MonooxygenaseDopamineTyrosine 3-Monooxygenase

Identifiers

PMID19731547
PMCPMC2779115
OpenAlexW1486520622

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.